DRKS00015626已完成2 期
imagin - online intervention for people with appearance related concerns - imagin
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •main diagnosis body dysmophic disorder (main study) / central problem appearance related concerns (side study)
- •- at least 18 years old
- •- at least 14 points in the Fragebogen körperdysmorpher Symptome (FKS)”
排除标准
- •- current psychotherapeutic treatment (outpatient/inpatient);
- •- cognitive-behavioural treatment of the Body Dysmorphic Disorder within the last 6 months;
- •- instable psychopharmacological medication within the last two months
- •- severe suicidality
- •- current Substance-related Addiction, current severe Major Depression, Bipolar Disorder, pre-diagnosed Schizophrenic Disorder or Borderline Personality Disorder
研究者
相似试验
已完成
不适用
Internet-based therapist-supported intervention for Binge Eating DisorderBinge Eating DisorderF50.9E66Eating disorder, unspecifiedObesityDRKS00000590Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Lepizig150
终止
不适用
Multimedia (MyStay) Intervention for managing patient experience (MIME) following total hip replacement surgery: a cluster randomised trial.Orthopeadic surgery - Hip replacement surgeryAcute postoperative careMusculoskeletal - OsteoarthritisSurgery - Other surgeryACTRN12618001241224Epworth HealthCare51
Unknown
不适用
Internet based self-guided intervention for COVID-19 related dysfunctional worryCTRI/2021/02/031286Department of Clinical Psychology National Institute of Mental health and NeurosciencesNIMHANS
已完成
不适用
The feasibility of an online lifestyle intervention for people with Multiple SclerosisNeurological - Multiple sclerosismultiple sclerosisACTRN12621000245897William Bevens35
进行中（未招募）
1 期
Interventional Platform Study Investigating the Impact of Digital Health Solutions on Health Outcomes and Health-Care Resource Utilization in Participants Receiving Systemic Treatment in Clinical Practice (ORIGAMA)Cohort A: •Metastatic non-small cell lung carcinoma (mNSCLC)•Extensive-stage small-cell lung carcinoma (ES-SCLC)•Advanced or unresectable hepatocellular carcinoma (HCC)Cohort B: •Resected Stage IIB-IIIB (early-stageper the UICC/AJCC staging system, 8th edition) non-small cell lung carcinoma (NSCLC)MedDRA version: 20.0Level: LLTClassification code: 10025064Term: Lung carcinoma Class: 10029104MedDRA version: 21.0Level: LLTClassification code: 10036706Term: Primary liver cancer non-resectable Class: 10029104CTIS2023-504342-55-00F. Hoffmann-La Roche AG235